$SoundHound AI(SOUN.US$Anyone heard apple wants to buyout
1
1
$NIO Inc(NIO.US$ $9 in 2 weeks
5
1
73958483
commented on
$NIO Inc(NIO.US$4.775.. based on chart, should rebound by today, else latest tomoro…
Disclaimer: not an inducement to buy/sell
Disclaimer: not an inducement to buy/sell
1
5
73958483
liked
Operating as a telehealth company, $Hims & Hers Health(HIMS.US$ connects patients with physicians through an app and automates medication fulfillment via its proprietary pharmacy facilities.
Here are the six key drivers influencing the company's growth:
1. Cost Advantage: $Hims & Hers Health(HIMS.US$ provides treatments for a growing number of conditions at prices lower than typical insurance-covered costs. This cost efficiency creates a strong competitive moat...
Here are the six key drivers influencing the company's growth:
1. Cost Advantage: $Hims & Hers Health(HIMS.US$ provides treatments for a growing number of conditions at prices lower than typical insurance-covered costs. This cost efficiency creates a strong competitive moat...
14
73958483
voted
$Hims & Hers Health(HIMS.US$ has added GLP-1 weight-loss injections to its portfolio of products.
The injections will have the same active ingredient as $Novo-Nordisk A/S(NVO.US$ ’s Ozempic and Wegovy.
HIMS stock is up by nearly 100% year-to-date.
Hims & Hers added that it would provide branded GLP-1 injections once supply catches up with demand. In the upcoming months, Hims & Hers will work towards providing access to compounded tirzepatide, whic...
The injections will have the same active ingredient as $Novo-Nordisk A/S(NVO.US$ ’s Ozempic and Wegovy.
HIMS stock is up by nearly 100% year-to-date.
Hims & Hers added that it would provide branded GLP-1 injections once supply catches up with demand. In the upcoming months, Hims & Hers will work towards providing access to compounded tirzepatide, whic...
4
$CAVA Group(CAVA.US$ looks good hope to move
$SoundHound AI(SOUN.US$ microsoft and NVIDA looking to purchase
5
8